Prot# 280: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Steroid-Refractory Acute GVHD

Project: Research project

Project Details

StatusFinished
Effective start/end date3/15/07 → 1/1/12

Funding

  • Quintiles, Inc. (280 // 280)
  • Osiris Therapeutics, Inc. (280 // 280)